|
ZNF146 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.171800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.683200E-01 |
| Normal-vs-Stage2 |
5.782600E-01 |
| Normal-vs-Stage3 |
7.241200E-03 |
| Normal-vs-Stage4 |
4.429700E-02 |
| Stage1-vs-Stage2 |
8.744800E-01 |
| Stage1-vs-Stage3 |
1.346170E-02 |
| Stage1-vs-Stage4 |
1.000620E-01 |
| Stage2-vs-Stage3 |
2.190400E-01 |
| Stage2-vs-Stage4 |
3.890000E-01 |
| Stage3-vs-Stage4 |
6.388800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.647700E-02 |
| Normal-vs-AfricanAmerican |
1.018640E-01 |
| Normal-vs-Asian |
8.687000E-01 |
| Caucasian-vs-AfricanAmerican |
6.208600E-01 |
| Caucasian-vs-Asian |
5.424400E-01 |
| AfricanAmerican-vs-Asian |
4.017800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.303900E-02 |
| Normal-vs-Female |
3.737600E-01 |
| Male-vs-Female |
2.211800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.070400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.551000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.978000E-02 |
| Normal-vs-Age(81-100Yrs) |
4.958800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.593400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.233200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.670000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.196600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.594400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.290200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.154190E-01 |
| Normal-vs-Grade 2 |
9.977600E-01 |
| Normal-vs-Grade 3 |
2.623800E-03 |
| Normal-vs-Grade 4 |
2.066100E-02 |
| Grade 1-vs-Grade 2 |
2.241400E-01 |
| Grade 1-vs-Grade 3 |
2.879000E-03 |
| Grade 1-vs-Grade 4 |
1.688470E-02 |
| Grade 2-vs-Grade 3 |
2.762100E-04 |
| Grade 2-vs-Grade 4 |
1.733750E-02 |
| Grade 3-vs-Grade 4 |
9.853000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.012800E-01 |
| Normal-vs-ccB subtype |
4.890000E-02 |
| ccA subtype-vs-ccB subtype |
2.126200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.161550E-01 |
| Normal-vs-N1 |
2.884600E-01 |
| N0-vs-N1 |
8.260400E-01 |
|
|
